More Business Wire
View Older Stories View Newer Stories-
Ent Emerges from Stealth to Bring Prevention Back to Cybersecurity
-
Berg Finance 2021 DAC Expected to be Repaid on the July Payment Date
-
Csquare, Inc. Files Registration Statement for Proposed Initial Public Offering
-
U.S. Bancorp Announces Quarterly Dividends
-
Kennedy Wilson Announces Expiration and Results of Fundamental Change Offer for Any and All of Its Outstanding 5.000% Senior Notes Due 2031
-
Choice Properties Real Estate Investment Trust Schedules Second Quarter 2026 Results Release
-
PIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Exchange Traded Series
-
PIMCO Canada Corp. Announces Quarterly Distributions for PIMCO Canada Exchange Traded Series
-
The Wizard of Oz at Sphere Surpasses $400 Million in Ticket Sales With Over 3 Million Total Tickets Sold
-
U.S. Bancorp Names Brian Mauney Head of Investor Relations
-
Intel Foundry Details Process Milestones and Future Innovation at VLSI Symposium
-
Sphere Studios Announces The Rocky Horror Picture Show at Sphere
-
AM Best Affirms Credit Rating of Mozart Insurance, Ltd.
-
HRC Fertility Joins 2026 San Francisco Pride as Community Sponsor/Human Rights Summit Participant
-
Ultrarunner Takes on Colorado River Crisis in 2,000-Mile Athletic Feat to Drive Action on Water Crisis
-
AM Best Removes From Under Review With Developing Implications and Affirms Credit Ratings of Vantage Risk Ltd. and Its Affiliates
-
Careismatic Brands Launches Healthcare Advisory Board
-
Quartz Fabricators Urge Trump Administration to Protect American Jobs and Housing Affordability at Section 201 USTR Hearing
-
Alight Names Industry Veteran Mary Armstrong-Flippo to Lead Absence Management Broker Relations Strategy
-
Integral Launches Privacy Sanitization App on Databricks Marketplace, Bringing Privacy Risk Assessment Directly Into Customer Environments
-
Homes.com Report: U.S. Median Home Price Increases to $395,000 in May as Sales Hold up Despite Higher Mortgage Rates
-
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
-
Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
-
Homes.com Shares Most Expensive Home Sales Across Major U.S. Markets in May
-
RLI Promotes Kevin Brownell to Vice President, Claim
-
Coke Florida Celebrates Grand Opening of New Orlando Distribution Center
-
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
-
JPMorganChase to Host Second-Quarter 2026 Earnings Call
-
Jefferies to Release its Second Quarter Financial Results on June 24, 2026
-
Granite Point Mortgage Trust Inc. Announces Second Quarter 2026 Common and Preferred Stock Dividends and Business Update
-
Lumentum Chair of the Board, Penny Herscher, and CEO, Michael Hurlston to Participate in Rome Conference on AI, Ethics and Governance
-
Dynex Capital Appoints Douglas Neal to Its Board of Directors
-
PennyMac Mortgage Investment Trust Announces Scott Sauer Joined Its Board of Trustees
-
DSM and LEO Stockholders Vote to Support Board Nominees in Preliminary Results of 2026 Annual Stockholder Meetings
-
First Internet Bancorp to Pay Cash Dividend
-
Mastercard Board of Directors Announces Quarterly Dividend
-
Mastercard Announces Annual Meeting Results
-
KBRA Releases 12 Things in Credit: May 2026
-
Suralink Launches Cloud Testing Suite to Bring Agentic Execution to Audit Engagements
-
TPG Mortgage Investment Trust, Inc. Announces Second Quarter 2026 Common Dividend of $0.24 per Share
-
Penguin Solutions Announces Third Quarter Fiscal 2026 Conference Call
-
Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference
-
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
-
MP Materials to Participate in the J.P. Morgan Natural Resources Conference
-
CareTrust REIT Announces Quarterly Dividend of $0.39 per Share
-
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Verastem Oncology Doses First Patient in TARGET-D 201 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Pancreatic Cancer
-
CEL-SCI Announces Closing of Offering
-
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
